| Elba A Turbat-herrera, MD | |
|
2451 University Hospital Dr Fl 1, Mobile, AL 36617-2300 | |
| (251) 471-7790 | |
| (251) 471-7096 |
| Full Name | Elba A Turbat-herrera |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 39 Years |
| Location | 2451 University Hospital Dr Fl 1, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992715080 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Usa Health University Hospital | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usa Health Physician Billing Services Llc | 9931436912 | 266 |
News Archive
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
Women in rural Bangladesh prefer inexpensive, traditional stoves for cooking over modern ones despite significant health risks, according to a Yale study in the Proceedings of the National Academy of Sciences.
The risk of dying from breast cancer was not related to high mammographic breast density in breast cancer patients, according to a study published August 20 in the Journal of the National Cancer Institute.
IsoRay, Inc. announced today another milestone in the use of Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy). Doctors at a world renowned medical facility have performed the world's first Cs-131 brachytherapy seed implant following a wedge resection of a lung tumor which originated from a form of malignant uterine cancer. Initially used to treat primary cancers, Cs-131 seeds are now being used to treat metastasized cancer.
› Verified 8 days ago
| Entity Name | University Of South Alabama |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746838 PECOS PAC ID: 3072425149 Enrollment ID: O20040115000773 |
News Archive
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
Women in rural Bangladesh prefer inexpensive, traditional stoves for cooking over modern ones despite significant health risks, according to a Yale study in the Proceedings of the National Academy of Sciences.
The risk of dying from breast cancer was not related to high mammographic breast density in breast cancer patients, according to a study published August 20 in the Journal of the National Cancer Institute.
IsoRay, Inc. announced today another milestone in the use of Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy). Doctors at a world renowned medical facility have performed the world's first Cs-131 brachytherapy seed implant following a wedge resection of a lung tumor which originated from a form of malignant uterine cancer. Initially used to treat primary cancers, Cs-131 seeds are now being used to treat metastasized cancer.
› Verified 8 days ago
| Entity Name | Usa Health Physician Billing Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720645468 PECOS PAC ID: 9931436912 Enrollment ID: O20190814000827 |
News Archive
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
Women in rural Bangladesh prefer inexpensive, traditional stoves for cooking over modern ones despite significant health risks, according to a Yale study in the Proceedings of the National Academy of Sciences.
The risk of dying from breast cancer was not related to high mammographic breast density in breast cancer patients, according to a study published August 20 in the Journal of the National Cancer Institute.
IsoRay, Inc. announced today another milestone in the use of Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy). Doctors at a world renowned medical facility have performed the world's first Cs-131 brachytherapy seed implant following a wedge resection of a lung tumor which originated from a form of malignant uterine cancer. Initially used to treat primary cancers, Cs-131 seeds are now being used to treat metastasized cancer.
› Verified 8 days ago
| Entity Name | Usa Health - Mci Business Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952972812 PECOS PAC ID: 6800290305 Enrollment ID: O20210805001329 |
News Archive
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
Women in rural Bangladesh prefer inexpensive, traditional stoves for cooking over modern ones despite significant health risks, according to a Yale study in the Proceedings of the National Academy of Sciences.
The risk of dying from breast cancer was not related to high mammographic breast density in breast cancer patients, according to a study published August 20 in the Journal of the National Cancer Institute.
IsoRay, Inc. announced today another milestone in the use of Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy). Doctors at a world renowned medical facility have performed the world's first Cs-131 brachytherapy seed implant following a wedge resection of a lung tumor which originated from a form of malignant uterine cancer. Initially used to treat primary cancers, Cs-131 seeds are now being used to treat metastasized cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elba A Turbat-herrera, MD Po Box 40480, Mobile, AL 36640-0480 Ph: (251) 434-3626 | Elba A Turbat-herrera, MD 2451 University Hospital Dr Fl 1, Mobile, AL 36617-2300 Ph: (251) 471-7790 |
News Archive
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
Women in rural Bangladesh prefer inexpensive, traditional stoves for cooking over modern ones despite significant health risks, according to a Yale study in the Proceedings of the National Academy of Sciences.
The risk of dying from breast cancer was not related to high mammographic breast density in breast cancer patients, according to a study published August 20 in the Journal of the National Cancer Institute.
IsoRay, Inc. announced today another milestone in the use of Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy). Doctors at a world renowned medical facility have performed the world's first Cs-131 brachytherapy seed implant following a wedge resection of a lung tumor which originated from a form of malignant uterine cancer. Initially used to treat primary cancers, Cs-131 seeds are now being used to treat metastasized cancer.
› Verified 8 days ago
Dr. Lloyd Gardner, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-460-0326 Fax: 251-460-2846 | |
Dr. Lee Fucich, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-460-0326 Fax: 251-460-2846 | |
Elizabeth A. Manci, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1700 Center St, Pathology, Mobile, AL 36604 Phone: 251-415-1612 Fax: 251-415-1003 | |
Carole Boudreaux, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2451 Fillingim St, Pathology, Mobile, AL 36617 Phone: 251-471-7790 Fax: 251-471-7715 | |
Jonathan Newsom, Pathology Medicare: Medicare Enrolled Practice Location: 2451 University Hospital Dr, Mobile, AL 36617 Phone: 251-470-9912 | |
Dr. Rodney Edwin Shackelford, DO Pathology Medicare: Medicare Enrolled Practice Location: 2451 University Hospital Dr, Mobile, AL 36617 Phone: 251-471-7790 Fax: 251-471-7096 | |
Eugene Hart, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2451 Fillingim St, Department Of Pathology, Mobile, AL 36617 Phone: 251-471-7026 |